Toshiya Inada Selected Research

Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)

9/2011	Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population.
8/2009	Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshiya Inada Research Topics

Disease

87	Schizophrenia (Dementia Praecox) 01/2023 - 04/2002
36	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 10/2004
16	Bipolar Disorder (Manic Depressive Psychosis) 03/2013 - 09/2004
11	Major Depressive Disorder (Major Depressive Disorders) 03/2024 - 01/2006
9	Substance-Related Disorders (Drug Abuse) 10/2008 - 10/2004
8	Mental Disorders (Mental Disorder) 10/2012 - 05/2009
7	Mood Disorders (Mood Disorder) 12/2012 - 07/2005
5	Delirium 05/2021 - 12/2003
5	Tardive Dyskinesia 08/2011 - 09/2003
4	Parkinsonian Disorders (Parkinsonism) 01/2021 - 10/2002
3	Inflammation (Inflammations) 01/2021 - 02/2008
3	Hallucinations (Hallucination) 01/2021 - 12/2007
3	Dyskinesias (Dyskinesia) 01/2021 - 01/2003
3	Psychomotor Agitation (Akathisia) 12/2017 - 10/2002
3	Genetic Predisposition to Disease (Genetic Predisposition) 03/2011 - 04/2008
3	Treatment-Resistant Schizophrenia 04/2008 - 07/2003
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2023 - 01/2021
2	Dementia (Dementias) 01/2021 - 08/2005
2	Autism Spectrum Disorder 12/2020 - 11/2020
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 12/2017
1	Torticollis (Wryneck) 04/2024
1	Catatonia 01/2023
1	Triple X syndrome 12/2022
1	Fatigue 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 05/2021
1	Tremor (Tremors) 01/2021
1	Obesity 01/2020
1	Muscle Rigidity 01/2020
1	Overweight 01/2020
1	Body Weight (Weight, Body) 01/2020

Drug/Important Bio-Agent (IBA)

36	Methamphetamine (Desoxyn)FDA LinkGeneric 08/2015 - 10/2004
19	Antipsychotic Agents (Antipsychotics)IBA 04/2024 - 04/2002
9	Proteins (Proteins, Gene)FDA Link 08/2014 - 07/2004
8	Serotonin (5 Hydroxytryptamine)IBA 04/2023 - 06/2009
7	Glutamic Acid (Glutamate)FDA Link 01/2022 - 04/2008
7	NucleotidesIBA 11/2020 - 12/2004
5	Dopamine (Intropin)FDA LinkGeneric 04/2023 - 10/2004
4	Messenger RNA (mRNA)IBA 01/2021 - 01/2008
4	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 08/2009 - 04/2008
4	Olanzapine (Zyprexa)FDA Link 12/2008 - 10/2002
4	Haloperidol (Haldol)FDA LinkGeneric 12/2007 - 10/2002
3	Biomarkers (Surrogate Marker)IBA 04/2023 - 03/2010
3	BenzodiazepinesIBA 05/2021 - 01/2021
3	Transcription Factors (Transcription Factor)IBA 01/2013 - 07/2005
3	serotonin 6 receptorIBA 01/2012 - 07/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2011 - 01/2009
3	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 03/2011 - 01/2009
3	EnzymesIBA 03/2011 - 03/2005
3	5-HT1A Serotonin ReceptorIBA 01/2011 - 11/2009
3	CannabinoidsIBA 05/2010 - 02/2008
3	Fluvoxamine (Luvox)FDA LinkGeneric 01/2010 - 01/2006
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2009 - 09/2004
3	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 05/2009 - 07/2001
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 10/2008
2	Nicotine FDA Link 01/2021 - 10/2008
2	Tryptophan HydroxylaseIBA 05/2012 - 03/2011
2	Phencyclidine (Angel Dust)IBA 12/2011 - 06/2009
2	N-Methylaspartate (NMDA)IBA 12/2011 - 08/2009
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2011 - 01/2008
2	Sirtuin 1IBA 10/2011 - 10/2010
2	Ubiquitin-Specific ProteasesIBA 09/2011 - 03/2010
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 09/2011 - 08/2009
2	Factor X (Stuart Factor)IBA 08/2011 - 03/2010
2	Dopamine AntagonistsIBA 08/2011 - 04/2010
2	perlecanIBA 08/2011 - 04/2010
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2011 - 08/2010
2	A-factor (Streptomyces)IBA 03/2011 - 07/2006
2	P-2 (P 2)IBA 09/2010 - 04/2010
2	EndocannabinoidsIBA 05/2010 - 03/2005
2	Estrogen Receptor alphaIBA 08/2009 - 08/2009
2	Neuregulin-1 (Neuregulin 1)IBA 08/2009 - 04/2008
2	DNA (Deoxyribonucleic Acid)IBA 10/2008 - 07/2006
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2008 - 02/2008
2	Serotonin ReceptorsIBA 04/2008 - 03/2008
2	Butyric Acid (Butanoic Acid)IBA 03/2007 - 09/2005
1	Antidepressive Agents (Antidepressants)IBA 03/2024
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2023
1	LigandsIBA 04/2023
1	blonanserinIBA 01/2023
1	Clozapine (Clozaril)FDA LinkGeneric 06/2022
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2022
1	CytokinesIBA 01/2022
1	SteroidsIBA 01/2022
1	suvorexantIBA 05/2021
1	Hypnotics and Sedatives (Sedatives)IBA 05/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021
1	ElectrolytesIBA 01/2021
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Histone DemethylasesIBA 12/2020
1	Histones (Histone)IBA 12/2020
1	rho GTPase-activating proteinIBA 01/2020

Therapy/Procedure

4	Therapeutics 03/2024 - 09/2003
2	Precision Medicine 06/2022 - 01/2022
2	Polypharmacy 01/2015 - 12/2014
1	Drug Therapy (Chemotherapy) 03/2024
1	Transdermal Patch 01/2023
1	Critical Care (Surgical Intensive Care) 01/2021
1	Injections 08/2019